InvestorsHub Logo

jammy32

09/22/22 8:00 AM

#373942 RE: The ELTP King #373941

That’s not what I read. I read that demand is spiking but they can’t fulfill that demand. Wtf

jour_trader

09/22/22 8:01 AM

#373943 RE: The ELTP King #373941

Early Oct release will benefit Q3.

sharkey1

09/23/22 11:06 AM

#374011 RE: The ELTP King #373941

Thanks King, to finish up the article (CP)
An unprecedented spike in Adderall prescriptions has prompted the supply issues. Previously, Bloomberg attributed the spike in prescriptions to a combination of increased diagnoses and greater availability of the medicine through online startups.

Par and Lannett did not reply to Fierce Pharma’s request for comment at the time of publication.

UH, DUH, guess no body saw that coming, some sort of increased demand just out of no where, the economy picked up and every back in school, The FDA has backed them selves in to a corner, Increase the API for generics, or have a shortage